Edible Vaccine Market Size Forecasted To Achieve $13.63 Billion By 2029 With Steady Growth

The Edible Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Edible Vaccine Market Size and Projected Growth Rate?
The edible vaccine market has experienced strong growth in recent years. It is forecasted to expand from $8.77 billion in 2024 to $9.6 billion in 2025, achieving a CAGR of 9.4%. Factors contributing to historical growth include advancements in genetic engineering, challenges associated with traditional vaccines, progress in biopharming, an increasing focus on global immunization, and growing government funding and support.

The edible vaccine market is poised for significant expansion in the upcoming years. By 2029, it is estimated to reach $13.63 billion, growing at a CAGR of 9.2%. Growth in this sector is attributed to increased demand for pandemic preparedness, progress in plant biotechnology, rising public awareness and acceptance of genetically modified foods, efforts to address cold chain challenges, and integration with food security initiatives. Key trends include the expansion into animal health, a rise in biopharming applications, the development of personalized nutrition and vaccination approaches, a focus on sustainability and green vaccines, and advancements in multi-antigen edible vaccines.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19040

What Are the Major Segments in the Edible Vaccine Market?
The edible vaccinemarket covered in this report is segmented -

1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals

Subsegments:
1) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
2) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
3) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines, Synthetic DNA Vaccines
4) By Live Attenuated Vaccines: Live Attenuated Viral Vaccines, Live Attenuated Bacterial Vaccines
5) By Other Types: Virus-Like Particle (VLP) Vaccines, mRNA Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp

What Are The Driving Edible Vaccine Market Evolution?
The increasing prevalence of infectious diseases is expected to drive the growth of the edible vaccine market. Infectious diseases are becoming more widespread due to factors like globalization, antibiotic resistance, and climate change. Edible vaccines, which offer a needle-free, cost-effective way to stimulate immune responses, are gaining popularity as an alternative to traditional vaccine delivery methods. In March 2024, the CDC reported an increase in tuberculosis cases in the US, which is indicative of the broader trend of rising infectious diseases. The growing need for more accessible and efficient vaccination methods is expected to boost the demand for edible vaccines.

Which Firms Dominate The Edible Vaccine Market Segments?
Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation

What Are the Major Trends Shaping the Edible Vaccine Market?
In the edible vaccine market, companies are focused on oral cholera vaccines (OCV) to combat global cholera outbreaks. For example, in August 2024, Bharat Biotech launched Hillchol, an oral cholera vaccine that offers ease of administration without requiring cold storage, making it ideal for use in resource-limited areas. The vaccine provides long-lasting immunity with just one dose.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report

Which Is The Largest Region In The Edible Vaccine Market?
North America was the largest region in the edible vaccine market in 2024. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Edible Vaccine Market?
2. What is the CAGR expected in the Edible Vaccine Market?
3. What Are the Key Innovations Transforming the Edible Vaccine Industry?
4. Which Region Is Leading the Edible Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.